BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23171028)

  • 1. Detection of lipid-rich prostate circulating tumour cells with coherent anti-Stokes Raman scattering microscopy.
    Mitra R; Chao O; Urasaki Y; Goodman OB; Le TT
    BMC Cancer; 2012 Nov; 12():540. PubMed ID: 23171028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coherent anti-Stokes Raman scattering imaging of lipids in cancer metastasis.
    Le TT; Huff TB; Cheng JX
    BMC Cancer; 2009 Jan; 9():42. PubMed ID: 19183472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced detection of metastatic prostate cancer cells in human plasma with lipid bodies staining.
    Mitra R; Goodman OB; Le TT
    BMC Cancer; 2014 Feb; 14():91. PubMed ID: 24528787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Label-free imaging of lipid dynamics using Coherent Anti-stokes Raman Scattering (CARS) and Stimulated Raman Scattering (SRS) microscopy.
    Folick A; Min W; Wang MC
    Curr Opin Genet Dev; 2011 Oct; 21(5):585-90. PubMed ID: 21945002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raman and coherent anti-Stokes Raman scattering microscopy studies of changes in lipid content and composition in hormone-treated breast and prostate cancer cells.
    Potcoava MC; Futia GL; Aughenbaugh J; Schlaepfer IR; Gibson EA
    J Biomed Opt; 2014; 19(11):111605. PubMed ID: 24933682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Label-free evaluation of hepatic microvesicular steatosis with multimodal coherent anti-Stokes Raman scattering microscopy.
    Le TT; Ziemba A; Urasaki Y; Brotman S; Pizzorno G
    PLoS One; 2012; 7(11):e51092. PubMed ID: 23226469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
    Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
    Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer.
    Amato RJ; Melnikova V; Zhang Y; Liu W; Saxena S; Shah PK; Jensen BT; Torres KE; Davis DW
    Urology; 2013 Jun; 81(6):1303-7. PubMed ID: 23622774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancer.
    Dong L; Zhang Z; Smith K; Kuczler MD; Reyes D; Amend SR; Cho YK; Xue W; Pienta KJ
    BJU Int; 2020 Jul; 126(1):191-201. PubMed ID: 32115854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector.
    Wu P; Sokoll LJ; Kudrolli TA; Chowdhury WH; Ma R; Liu MM; Rodriguez R; Lupold SE
    Prostate; 2014 Sep; 74(13):1286-1296. PubMed ID: 25065656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shedding new light on lipid biology with coherent anti-Stokes Raman scattering microscopy.
    Le TT; Yue S; Cheng JX
    J Lipid Res; 2010 Nov; 51(11):3091-102. PubMed ID: 20713649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trial.
    Brady L; Hayes B; Sheill G; Baird AM; Guinan E; Stanfill B; Vlajnic T; Casey O; Murphy V; Greene J; Allott EH; Hussey J; Cahill F; Van Hemelrijck M; Peat N; Mucci L; Cunningham M; Grogan L; Lynch T; Manecksha RP; McCaffrey J; O'Donnell D; Sheils O; O'Leary J; Rudman S; McDermott R; Finn S
    PLoS One; 2020; 15(12):e0243928. PubMed ID: 33338056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.
    Cann GM; Gulzar ZG; Cooper S; Li R; Luo S; Tat M; Stuart S; Schroth G; Srinivas S; Ronaghi M; Brooks JD; Talasaz AH
    PLoS One; 2012; 7(11):e49144. PubMed ID: 23145101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogous detection of circulating tumor cells using the AccuCyte
    van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
    Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer.
    Goodman OB; Symanowski JT; Loudyi A; Fink LM; Ward DC; Vogelzang NJ
    Clin Genitourin Cancer; 2011 Sep; 9(1):31-8. PubMed ID: 21705286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolin Staining May Aid in the Identification of Circulating Prostate Cancer Cells.
    Chalfin HJ; Verdone JE; van der Toom EE; Glavaris S; Gorin MA; Pienta KJ
    Clin Genitourin Cancer; 2017 Jun; 15(3):e477-e481. PubMed ID: 28153390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer.
    Sharp A; Welti JC; Lambros MBK; Dolling D; Rodrigues DN; Pope L; Aversa C; Figueiredo I; Fraser J; Ahmad Z; Lu C; Rescigno P; Kolinsky M; Bertan C; Seed G; Riisnaes R; Miranda S; Crespo M; Pereira R; Ferreira A; Fowler G; Ebbs B; Flohr P; Neeb A; Bianchini D; Petremolo A; Sumanasuriya S; Paschalis A; Mateo J; Tunariu N; Yuan W; Carreira S; Plymate SR; Luo J; de Bono JS
    Eur Urol; 2019 Nov; 76(5):676-685. PubMed ID: 31036442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer.
    Broncy L; Paterlini-Bréchot P
    Cells; 2019 Jul; 8(7):. PubMed ID: 31277346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment and mutation detection of circulating tumor cells from blood samples.
    Kou R; Zhao J; Gogoi P; Carskadon S; Chow W; Hwang C; Palanisamy N; Leung C; Wang Y
    Oncol Rep; 2018 Jun; 39(6):2537-2544. PubMed ID: 29620284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.